Scientists identified interferon regulatory factor (IRF8) as an important prognostic biomarker in hepatocellular carcinoma patients which predicted the response and sensitivity to anti-PD-1 therapy.
[Hepatology]
7992332
{7992332:EEEEEEEE}
apa
50
1
170437
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
